BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24495728)

  • 1. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
    Zhang J; Zeng Y; Zheng J; Xu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
    Zhang G; Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
    Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
    Babichenko II; Grigor'ian AS; Katushkina AA
    Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
    Liang X; Mao Z; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
    Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
    Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Gorecki P; Neukam FW; Strassburg LH; Nkenke E
    Cancer Invest; 2012 Aug; 30(7):495-502. PubMed ID: 22646284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
    Patel S; Metgud R
    J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW; Hu BQ; Cao CF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine expression in oral squamous cell carcinoma and leukoplakia.
    Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
    J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.